Here's the live share price of Sun Pharmaceutical Industries along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Sun Pharmaceutical Industries has gained 27.56% CAGR. Over the past year, the corresponding return has been -12.72%.
Sun Pharmaceutical Industries’s current P/E of 38.42x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries | 1.64 | 3.49 | -4.01 | -2.74 | -12.60 | 19.25 | 27.64 |
Divi's Laboratories | 6.85 | 8.10 | -3.63 | 14.13 | 7.12 | 22.26 | 16.05 |
Cipla | 3.52 | -0.04 | 3.79 | 4.45 | -1.53 | 11.74 | 15.00 |
Torrent Pharmaceuticals | -0.44 | 0.54 | 3.25 | 10.11 | 1.54 | 30.97 | 21.17 |
Dr. Reddy's Laboratories | 0.26 | -4.87 | -1.87 | 7.07 | -6.50 | 12.60 | 4.12 |
Mankind Pharma | -0.57 | -5.71 | -8.15 | 0.34 | -11.27 | 19.60 | 11.34 |
Zydus Lifesciences | 0.27 | -4.62 | 2.24 | 11.83 | -6.56 | 33.20 | 18.94 |
Lupin | 2.47 | -4.59 | 0.08 | -2.94 | -13.21 | 41.41 | 14.25 |
Alkem Laboratories | 1.60 | 1.46 | 13.11 | 13.30 | -10.85 | 21.29 | 15.97 |
Aurobindo Pharma | 4.69 | 1.94 | -2.78 | -1.33 | -24.31 | 29.15 | 7.19 |
Abbott India | 0.26 | -3.20 | -12.79 | -3.43 | 3.11 | 18.31 | 13.41 |
Glenmark Pharmaceuticals | -1.01 | -9.19 | -14.40 | 38.59 | 5.63 | 69.13 | 32.09 |
Biocon | 1.65 | -1.12 | -9.16 | 7.64 | 0.58 | 10.35 | -3.95 |
Laurus Labs | 2.13 | -1.95 | 5.98 | 40.16 | 81.95 | 19.61 | 22.65 |
GlaxoSmithKline Pharmaceuticals | 0.41 | -0.58 | -14.40 | -4.79 | 1.10 | 25.87 | 12.55 |
Anthem Biosciences | 0.56 | -7.23 | 6.03 | 6.03 | 6.03 | 1.88 | 1.12 |
Ipca Laboratories | -3.23 | 0.02 | -10.87 | -3.93 | -23.00 | 13.63 | 4.73 |
Cohance Lifesciences | 0.66 | -11.96 | -17.88 | -26.82 | -28.33 | 30.09 | 20.15 |
Gland Pharma | -1.79 | -4.68 | 1.31 | 34.66 | 16.43 | -3.75 | 1.08 |
Ajanta Pharma | 0.22 | -5.32 | -10.61 | -7.94 | -26.79 | 24.31 | 18.60 |
Over the last one year, Sun Pharmaceutical Industries has declined 12.60% compared to peers like Divi's Laboratories (7.12%), Cipla (-1.53%), Torrent Pharmaceuticals (1.54%). From a 5 year perspective, Sun Pharmaceutical Industries has outperformed peers relative to Divi's Laboratories (16.05%) and Cipla (15.00%).
Day | SMA | EMA |
---|---|---|
5 | 1,656.73 | 1,656.77 |
10 | 1,639.36 | 1,648.19 |
20 | 1,632.43 | 1,637.29 |
50 | 1,620.91 | 1,635.35 |
100 | 1,651.48 | 1,653.11 |
200 | 1,696.93 | 1,670.53 |
In the latest quarter, Sun Pharmaceutical Industries saw a rise in promoter holding to 98.11%, while DII stake increased to 19.49%, FII holding fell to 17.26%, and public shareholding moved down to 8.50% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
SBI Nifty 50 ETF | 1,88,98,269 | 1.49 | 3,012.95 |
ICICI Prudential Value Discovery Fund | 1,55,03,015 | 4.46 | 2,471.65 |
ICICI Prudential Equity & Debt Fund | 1,33,74,589 | 4.6 | 2,132.31 |
SBI BSE Sensex ETF | 1,30,16,008 | 1.77 | 2,075.99 |
ICICI Prudential Bluechip Fund | 1,17,71,629 | 2.57 | 1,876.75 |
HDFC Balanced Advantage Fund - Regular Plan | 67,84,634 | 1.05 | 1,081.67 |
Nippon India Pharma Fund | 62,56,349 | 12.29 | 997.45 |
ICICI Prudential Multi Asset Fund | 62,17,441 | 1.46 | 991.25 |
HDFC Top 100 Fund - Regular Plan | 60,54,009 | 2.52 | 965.19 |
UTI Nifty 50 ETF | 59,58,353 | 1.49 | 949.94 |
Price | (%) As on Invalid Date IST |
Open Interest | (%) |
High | |
Low | |
Open | |
Close | |
Contract Traded | |
Turnover (in lakhs) |
Date Time | Announcement |
---|---|
Oct 14, 2025, 11:22 PM IST | Sun Pharma. - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30 Sep |
Oct 14, 2025, 10:18 PM IST | Sun Pharma. - ESG Overview For FY 2024-25 |
Oct 09, 2025, 1:53 AM IST | Sun Pharma. - Announcement under Regulation 30 (LODR)-Scheme of Arrangement |
Oct 07, 2025, 8:09 PM IST | Sun Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Sep 18, 2025, 9:55 PM IST | Sun Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Sun Pharmaceutical Industries Ltd. is a Public Limited Listed company incorporated on 01/03/1993 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1993PLC019050 and registration number is 019050. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 23003.33 Cr. and Equity Capital is Rs. 239.93 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Sun Pharmaceutical Industries is ₹1,657.20 as on Oct 15, 2025.
The Sun Pharmaceutical Industries is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Sun Pharmaceutical Industries is ₹398,541.54 Cr as on Oct 15, 2025.
Today’s highest and lowest price of Sun Pharmaceutical Industries are ₹1,668.20 and ₹1,648.40.
The 52-week high/low is the highest and lowest price at which Sun Pharmaceutical Industries stock has traded in the past 52-week or nearly a year. The 52-week high of Sun Pharmaceutical Industries is ₹1,924.95 and 52-week low of Sun Pharmaceutical Industries is ₹1,547.25 as on Oct 15, 2025.
The Sun Pharmaceutical Industries has shown returns of 0.12% over the past day, 3.35% for the past month, -4.14% over 3 months, -12.72% over 1 year, 19.12% across 3 years, and 27.56% over 5 years.
P/E ratio of and PB ratio of Sun Pharmaceutical Industries are 38.42 and 5.77 on Oct 15, 2025. While the company gives a dividend yield of 0.96 per annum.